Hologix
OrganizationMentions
3
Relationships
1
Events
1
Documents
1
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
1 total relationships
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
ICA
|
Acquirer target |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Acquisition of Interlace Medical by Hologix | N/A | View |
HOUSE_OVERSIGHT_024052.jpg
This document appears to be page 41 of a confidential investment memorandum for 'New Leaf,' specifically regarding their third fund, NLV-III. It outlines the 'Medical Devices Investment Strategy,' emphasizing a shift toward later-stage opportunities due to regulatory headwinds in the U.S. and E.U. The document cites specific portfolio successes like Neuronetics, CardioKinetix, and the acquisition of Interlace Medical by Hologix to demonstrate the team's track record.
Investment memorandum / fund strategy report
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity